MAPT and Alzheimer disease: Given that this pre-diabetic impairment in systemic glucose control and insulin sensitivity can potentially contribute to the pathogenesis of AD, our results suggest that a simple dietary intervention of limiting BCAA intake is effective in not only reducing amyloid and Tau burden in the brain, but also in correcting metabolic dysregulation.